Company intelligence / Profile preview
Vaxine
Adelaide, South Australia, Australiavaxine.net ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Commercial
01
Overview
Vaxine has developed several vaccine candidates using its proprietary Advax™ adjuvant technology. Its COVID‑19 vaccine candidate has advanced through clinical trials and demonstrated safety and immunogenicity. The company also develops influenza and other infectious disease vaccines.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Protein subunit vaccinesVirus-like particle (VLP) vaccinesAdjuvanted vaccines
- Industry
- Biotech
02
Drug pipeline
26 assets25 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with Flinders University, South Australia Health & Medical Research Institute, and international research groups for clinical development.Partnerships with government agencies during the COVID pandemic for rapid vaccine development support.
Beyond the preview
Go deeper on Vaxine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vaxine.